Editas Medicine, Inc. EDIT 37.68
Health Care · NASDAQ · Data as of 2026-09-09
Editas Medicine, Inc. (EDIT) has delivered +17.2% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1553 of 1968 stocks overall and #193 of 260 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
37.68
Overall Rank
#1553 / 1968
Sector Rank
#193 / 260
Revenue CAGR
+17.2%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio